TY - JOUR
T1 - Maximal Ca2+-activated force elicited by tetanization of ferret papillary muscle and whole heart
T2 - Mechanism and characteristics of steady contractile activation in intact myocardium
AU - Marban, E.
AU - Kusuoka, H.
AU - Yue, D. T.
PY - 1986
Y1 - 1986
N2 - Rapid (8-12 Hz) stimulation of intact heart muscle treated with ryanodine results in steady contractile activation known as tetanus, the amplitude of which can be graded by changing extracellular Ca2+ concentration ([Ca2+](o)). The mechanism of the sustained force generation was explored in ferret papillary muscles by measuring membrane potential and by determining the responsiveness of force and intracellular free Ca2+ concentration ([Ca2+](i), estimated with aequorin) to dihydropyridine Ca channel ligands. Membrane potential during tetani ranged from -25 to -60 mV, suggesting that fast or slow Ca channels, or Na-Ca exchange, might be mediating Ca2+ entry. Dihydropyridine effects indicated that slow Ca channels play a predominant role: The agonist Bay K 8644 (0.3-1 μM) increased force and aequorin luminescence, whereas the antagonist nitrendipine (1-30 μM) abolished the tetanus. Under conditions analogous to those in the papillary muscle experiments, tetani were produced in whole Langendorff-perfused ferret hearts following exposure to ryanodine. Contraction saturated as a function of [Ca2+](o) in both papillary muscles and whole hearts; i.e., as [Ca2+](o) was increased above 10 mM, no further increase in force or pressure generation occurred. In contrast, aequorin luminescence measured in the papillary muscles showed no such saturation. Thus, maximal Ca2+-activated force (or pressure) was achieved during tetani at [Ca2+](o) ≥ 10 mM. Calculations of wall stress during tetani in whole heart (15 mM [Ca2+](o)) agree well with direct measurements of maximal tension in papillary muscles (5.84 g/mm2 vs. 6.41 g/mm2, respectively). We conclude that maximal Ca2+-activated force (or pressure) can be produced during tetani at high [Ca2+](o) in either whole hearts or isolated papillary muscles following exposure to ryanodine.
AB - Rapid (8-12 Hz) stimulation of intact heart muscle treated with ryanodine results in steady contractile activation known as tetanus, the amplitude of which can be graded by changing extracellular Ca2+ concentration ([Ca2+](o)). The mechanism of the sustained force generation was explored in ferret papillary muscles by measuring membrane potential and by determining the responsiveness of force and intracellular free Ca2+ concentration ([Ca2+](i), estimated with aequorin) to dihydropyridine Ca channel ligands. Membrane potential during tetani ranged from -25 to -60 mV, suggesting that fast or slow Ca channels, or Na-Ca exchange, might be mediating Ca2+ entry. Dihydropyridine effects indicated that slow Ca channels play a predominant role: The agonist Bay K 8644 (0.3-1 μM) increased force and aequorin luminescence, whereas the antagonist nitrendipine (1-30 μM) abolished the tetanus. Under conditions analogous to those in the papillary muscle experiments, tetani were produced in whole Langendorff-perfused ferret hearts following exposure to ryanodine. Contraction saturated as a function of [Ca2+](o) in both papillary muscles and whole hearts; i.e., as [Ca2+](o) was increased above 10 mM, no further increase in force or pressure generation occurred. In contrast, aequorin luminescence measured in the papillary muscles showed no such saturation. Thus, maximal Ca2+-activated force (or pressure) was achieved during tetani at [Ca2+](o) ≥ 10 mM. Calculations of wall stress during tetani in whole heart (15 mM [Ca2+](o)) agree well with direct measurements of maximal tension in papillary muscles (5.84 g/mm2 vs. 6.41 g/mm2, respectively). We conclude that maximal Ca2+-activated force (or pressure) can be produced during tetani at high [Ca2+](o) in either whole hearts or isolated papillary muscles following exposure to ryanodine.
UR - http://www.scopus.com/inward/record.url?scp=0022929836&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022929836&partnerID=8YFLogxK
U2 - 10.1161/01.RES.59.3.262
DO - 10.1161/01.RES.59.3.262
M3 - Article
C2 - 2429779
AN - SCOPUS:0022929836
SN - 0009-7330
VL - 59
SP - 262
EP - 269
JO - Circulation research
JF - Circulation research
IS - 3
ER -